Package 25021-181-99

Brand: piperacillin, tazobactam

Generic: piperacillin sodium, tazobactam sodium
NDC Package

Package Facts

Identity

Package NDC 25021-181-99
Digits Only 2502118199
Product NDC 25021-181
Description

1 BOTTLE in 1 CARTON (25021-181-99) / 152 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2021-02-28
Brand piperacillin, tazobactam
Generic piperacillin sodium, tazobactam sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "a6724256-14c5-4408-83a5-a964f146f0d5", "openfda": {"unii": ["M98T69Q7HP", "UXA545ABTT"], "rxcui": ["312447"], "spl_set_id": ["83f4adcd-893c-4e9e-8f2b-e06299dcf34d"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (25021-181-99)  / 152 mL in 1 BOTTLE", "package_ndc": "25021-181-99", "marketing_start_date": "20210228"}], "brand_name": "Piperacillin, Tazobactam", "product_id": "25021-181_a6724256-14c5-4408-83a5-a964f146f0d5", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "25021-181", "generic_name": "Piperacillin Sodium, Tazobactam Sodium", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin, Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "36 g/152mL"}, {"name": "TAZOBACTAM SODIUM", "strength": "4.5 g/152mL"}], "application_number": "ANDA208675", "marketing_category": "ANDA", "marketing_start_date": "20210228", "listing_expiration_date": "20261231"}